Two Sigma Investments
OACC

Two Sigma Investments’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Two Sigma Investments’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.63M Hold
437,500
– – ﹤0.01% 2047
2025
Q4 		$4.63M Hold
437,500
– – 0.01% 1780
2025
Q3 		$4.6M Hold
437,500
– – 0.01% 1530
2025
Q2 		$4.57M Hold
437,500
– – 0.01% 1274
2025
Q1 		$4.48M Hold
437,500
– – 0.01% 1189
2024
Q4 		$4.36M Buy
+437,500
New +$4.37M 0.01% 1190

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Two Sigma Investments's OACC Position: Q1 2026 in Review

Two Sigma Investments held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 437,500 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2047.

Two Sigma Investments first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Two Sigma Investments held 437,500 shares of Oaktree Acquisition Corp III Life Sciences worth $4.63M as of Q1 2026.
  • Two Sigma Investments left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2047 holding.
  • Two Sigma Investments first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.